Home > Quotes > OPXAW

Opexa Therapeutics, Inc. Warrant Quote & Summary Data

Get OPXAW Alerts
*Delayed - data as of May 3, 2016  -  Find a broker to begin trading OPXAW now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OPXAW After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Opexa Therapeutics, Inc. Warrant Intraday Chart

News for OPXAW

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 0.07 $ 0.29
Low $ 0.06 $ 0.05

The current last sale of $0.0699 is 39.80% Higher thanthe 52 week low.

Company Description (as filed with the SEC)

Unless otherwise indicated, we use "Opexa," "the Company," "we," "our" and "us" to refer to the businesses of Opexa Therapeutics, Inc. Opexa is a biopharmaceutical company developing a personalized immunotherapy with the potential to treat major illnesses, including multiple sclerosis (MS) as well as other autoimmune diseases such as neuromyelitis optica (NMO). These therapies are based on our proprietary T-cell technology. Our mission is to lead the field of Precision Immunotherapy┬« by aligning the interests of patients, employees and shareholders. Information related to our product candidates, Tcelna┬« and OPX-212, is preliminary and investigative. Tcelna and OPX-212 have not been approved by the U.S. Food and Drug Administration (FDA) or other global regulatory agencies for marketing.  ... More ...  

Nasdaq Official Price

Research Brokers before you trade

Want to trade FX?